Vitro medis is a company founded by scientists, high-tech specialists and experts in their field, develops and applies the latest discoveries in medicine and actively works with the introduction of innovations in the market.
The team of scientists gathered at Vitro medis have many years of work experience and impressive scientific knowledge in developing medical innovations. Each individual member of the team represents himself as a scientist in various associations, participates in global conferences and symposiums and actively carries out scientific activities in his field.
​
Vitro medis always adheres to its original intention, constantly develops new products, improves services, and strives to create a one-stop professional scientific research platform.
​
EU Projects
Development of clinically relevant biomarkers in extracellular systems for gastrointestinal monitoring
Vitro Medis in October 2022, signed a financing agreement with the Public Enterprise Lithuanian Business Support Agency regarding the financing of the project with EU support funds under measure no. 01.2.1-LVPA-K-856 "Experiment". Project title "Development of clinically relevant biomarkers in extracellular systems for monitoring the digestive tract". During the project, it was planned to create two completely new products for the monitoring of the digestive tract - (1) a set of molecular markers, the differences in expression of which will have clinical significance in differentiating hepatocellular carcinoma of the digestive tract system from benign lesions, and (2) a molecular diagnostic kit that allows the detection of liver fibrosis. Clinically relevant markers were screened and selected during the research and experimental development activities implemented in the project.
